Skip to main content
Signal8

Aghion Daniel

SEC insider (Form 3/4/5 filer). CIK 0002004805. Director at ORAMED PHARMACEUTICALS INC. (ORMP). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 31, 2025. Located in NEW YORK, NY.

Companies Aghion Daniel has filed insider reports for

  • ORAMED PHARMACEUTICALS INC. (ORMP): Director
Aghion Daniel profile photo

Aghion Daniel

CIK: 0002004805

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ORAMED PHARMACEUTICALS INC. logo
ORMP

ORAMED PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Dec 31, 2025
    Award
    Direct
    30K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Dec 31, 2025
    Award
    Direct
    6.3K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Jun 5, 2025
    Award
    Direct
    30K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Jun 5, 2025
    Award
    Direct
    8.4K shares-

1-4 of 4